Hydroxyalkyne–Bithiophene Derivatives: Synthesis and Antileishmanial Activity
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70167 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2025. Written by Rayanne Regina Beltrame Machado and 8 co-authors. Institution: Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Departamento de Ciências Básica da Saúde, Universidade Estadual de M…. Major MEDLINE topics: Thiophenes, Antiprotozoal Agents, Leishmania, Alkynes. Cited 2 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundação Araucária, Programa de Apoio ao Núcleo de Excelência (PRONEX), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Abstract (original language)
Leishmaniasis is one of the most important neglected tropical diseases, prevalent in underdeveloped or developing countries, and new pharmacological agents for this disease are urgently needed. In this study, thiophene derivatives based on the natural product 5′‐methyl‐(5‐[4‐acetoxy‐1‐butynyl])‐2,2′‐bithiophene were synthesized and evaluated against promastigote forms of Leishmania amazonensis . The bithiophene BT‐1 was the most potent and selective synthetic compound toward the parasites, exhibiting IC 50 of 23.2 μM against promastigotes and CC 50 of 216.5 μM against macrophages, and its mechanism of action was determined through biochemical and ultrastructural analyses. An accumulation of lipid bodies, loss of cellular content, increased reactive oxygen species production and lipid peroxidation, damage to the plasma membrane, and mitochondrial depolarization were observed in BT‐1 ‐treated parasites. The results indicated that the death of L. amazonensis induced by BT‐1 occurred via destabilizing the parasite's redox homeostasis. Our results also showed that the synthesis based on the natural compound scaffold consisted of useful strategies to obtain new synthetic antileishmanial compounds.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratório de Inovação Tecnológica no Desenvolvimento de Fármacos e Cosméticos, Departamento de Ciências Básica da Saúde, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
- Programa de Pós-Graduação Em Química, Departamento de Química, Universidade Estadual de Maringá (UEM), Maringá, Brazil.
ORCID profiles: Rayanne Regina Beltrame Machado, Carla Maria Beraldi Gomes, Sueli de Oliveira Silva, Maria Helena Sarragiotto, Danielle Lazarin-Bidóia
Funding
- Fundação Araucária
- Programa de Apoio ao Núcleo de Excelência (PRONEX)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Capacitação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Universidade Estadual de Maringá (UEM)
- Complexo de Centrais de Apoio à Pesquisa-UEM
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Cite
APA
Machado, R. R. B., Salvador, D. L., Gomes, C. M. B., Bakoshi, A. B. K., Ueda-Nakamura, T., de Oliveira Silva, S., Nakamura, C. V., Sarragiotto, M. H., & Lazarin-Bidóia, D. (2025). Hydroxyalkyne–Bithiophene Derivatives: Synthesis and Antileishmanial Activity. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70167
Vancouver
Machado RRB, Salvador DL, Gomes CMB, Bakoshi ABK, Ueda-Nakamura T, de Oliveira Silva S, et al. Hydroxyalkyne–Bithiophene Derivatives: Synthesis and Antileishmanial Activity. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70167
BibTeX
@article{Machado2025,
author = {Machado, Rayanne Regina Beltrame and Salvador, Deysiane Lima and Gomes, Carla Maria Beraldi and Bakoshi, Amanda Beatriz Kawano and Ueda-Nakamura, Tânia and de Oliveira Silva, Sueli and Nakamura, Celso Vataru and Sarragiotto, Maria Helena and Lazarin-Bidóia, Danielle},
title = {Hydroxyalkyne–Bithiophene Derivatives: Synthesis and Antileishmanial Activity},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70167}
}
EUVIMED